MGMT and metastatic colorectal cancer: Identification of plasma ctDNA with MGMT methylation using methyl-BEAMing and bisulfite-pyrosequencing techniques in metastatic colorectal cancers demonstrated 86% agreement of MGMT methylation status the tumor and ctDNA analyses with the most methylated allele in the tissues presented in the circulation.